APL is classified as the M3 subtype of AML in the French American British system and classified as APL with t(15;17) (q22;q12), promyelocytic leukaemia–retinoic acid receptor‐alpha (PML–RARα) by the WHO.1 Here, PML is linked to acute promyelocytic leukemia.